Clinical practice audit concerning antimicrobial prophylaxis in paediatric neurosurgery: results from a German paediatric oncology unit

被引:5
|
作者
Weiss, Katja [1 ]
Simon, Arne [1 ]
Graf, Norbert [1 ]
Schoepe, Jakob [2 ]
Oertel, Joachim [3 ]
Linsler, Stefan [3 ]
机构
[1] Univ Hosp Childrens Clin, Paediat Oncol & Haematol, D-66421 Homburg, Saar, Germany
[2] Univ Saarland, Inst Med Biometry Epidemiol & Med Informat, Campus Homburg, Homburg, Saar, Germany
[3] Univ Saarland, Univ Hosp, Sch Med, Dept Neurosurg, Kirrbergerstr Bldg 90, D-66421 Homburg, Saar, Germany
关键词
Paediatric oncology; Neurosurgery; Perioperative antimicrobial prophylaxis; Quality improvement in health care; SURGICAL ANTIBIOTIC-PROPHYLAXIS; HEALTH-CARE; INFECTIONS; HOSPITALS; CHILDREN; SURGERY; STEWARDSHIP; MENINGITIS; CRANIOTOMY; PREVENTION;
D O I
10.1007/s00381-016-3279-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Perioperative antimicrobial prophylaxis (PAP) has been identified as an important target for internal audits, concerning the judicious use of antibiotics. Paediatric oncology patients with brain tumours face an increased risk of surgical site infection (SSI) after neurosurgery and receive routine PAP in this setting. All patients younger than 18 years admitted to the paediatric oncology centre (POC) with a neurosurgical intervention. Systematic audit of routine clinical data is divided in two groups: retrospective (Jan 01, 2012-March 31, 2014) and prospective (April 01, 2014-March 31, 2015) referring to an internal PAP guideline, invented in Jan. 2014). Surveillance of SSI up to 30 days after the operation with standard criteria (Centres for Disease Control and Prevention, USA). In total, 53 neurosurgical operations were analysed in 33 paediatric oncology patients. Twelve patients received more than one operation. The detailed analysis of PAP revealed prophylactic cefuroxim doses about 30 mg/kg instead of 50 mg/kg and no repeated dosing in operations lasting longer than 4 h. In addition, Cefotaxim, which is not indicated as PAP in neurosurgery, was used instead of Cefuroxim (or Ampicillin-Sulbactam) in 23 % of all cases in the retrospective and 18 % of all cases in the prospective audit. PAP for more than 3 doses (> 24 h) was administered in 66 % in the retrospective group and in 60 % in the prospective group (p = n.s.). In both groups, no SSI was detected. This first comprehensive audit of PAP in paediatric oncology patients undergoing neurosurgery outlines significant opportunities to improve clinical practice in terms of correct dosing, the correct choice of the antibiotic, a correct timing schedule and a shorter duration of PAP. In addition, our results illustrate in detail the challenges in clinical practice when an evidence-based approach to improve a standard workflow has to be implemented.
引用
收藏
页码:159 / 169
页数:11
相关论文
共 50 条
  • [41] CVAD (Central Venous Access Device) Removal Practice in Paediatric Haematology Oncology Unit at Tertiary Centre in UK
    Collins, L.
    Ross, E.
    Bhuller, K.
    Uparkar, U.
    Ismail, R.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S456 - S456
  • [42] PAEDIATRIC FOOD ALLERGY CLINIC IN A REGIONAL UNIT: CLINICAL PERFORMANCE IN THE CONTEXT OF NATIONAL PRACTICE GUIDELINES
    Barsoum, Zakaria
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2021, 57 (02) : 309 - 310
  • [43] Development and implementation of a patient reported outcome intervention (QLIC-ON PROfile) in clinical paediatric oncology practice
    Engelen, Vivian
    Haverman, Lotte
    Koopman, Hendrik
    Schouten-van Meeteren, Netteke
    Meijer-van den Bergh, Esther
    Vrijmoet-Wiersma, Jantien
    van Dijk, Elisabeth Maria
    Last, Bob
    Detmar, Symone
    Grootenhuis, Martha
    PATIENT EDUCATION AND COUNSELING, 2010, 81 (02) : 235 - 244
  • [44] Improving transitional experience from paediatric to adult diabetes services: audit results of a novel model
    Porteous, T. E.
    Lawrence, V. J.
    Whittingstall, E. R.
    DIABETIC MEDICINE, 2017, 34 : 20 - 20
  • [45] An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy
    Brown, E. C. M.
    Caimino, C.
    Benton, C. L.
    Baguley, D. M.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2021, 135 (01): : 14 - 20
  • [46] Ethical issues of clinical trials in paediatric oncology from 2003 to 2013: a systematic review
    Dupont, Jean-Claude K.
    Pritchard-Jones, Kathy
    Doz, Francois
    LANCET ONCOLOGY, 2016, 17 (05): : E187 - E197
  • [47] The treatment of gout: Results from the gema audit of clinical practice
    Ruiz, Fernando Perez
    Carmona, Loreto
    Pascual, Eliseo
    De Miguel, Eugenio
    Gonzalez-Gay, Miguel A.
    Urena, Inmaculada
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S177 - S177
  • [48] ANTIMICROBIAL RESISTANCE IN HELICOBACTER PYLORI SPANISH CLINICAL ISOLATES OBTAINED FROM PAEDIATRIC PATIENTS
    Alarcon, T.
    Martinez, M. J.
    Urruzuno, P.
    Barrio, J.
    Martianez, J.
    Llorca, L.
    Lopez-Brea, M.
    HELICOBACTER, 2012, 17 : 90 - 91
  • [49] Homer's syndrome in patients admitted to the paediatric intensive care unit: epidemiology, diagnosis and clinical practice
    Lazar, I.
    Cavari, Y.
    Rosenberg, E.
    Knyazer, B.
    ANAESTHESIA AND INTENSIVE CARE, 2013, 41 (01) : 20 - 23
  • [50] Unraveling L-asparaginase adverse reactions in paediatric acute lymphocytic leukaemia - A comprehensive case series from a paediatric oncology unit at a tertiary care center
    Kushwah, Anjali
    Kamle, Akshay
    Malpani, Preeti
    Chaudhary, Prachi
    Mishra, Pooja Solanki
    Acharya, Preeti
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2024, 13 (03) : 174 - 179